Vnitr Lek 2006, 52(9):782-789

Diuretics in therapy of "diuretic resistance" by patients with congestive heart failure

P. Tůma*, P. Hrdý
Interní klinika IPVZ Krajské nemocnice T. Bati, Zlín, přednosta prim. MUDr. Ivo Oral, CSc.

Loop diuretics are integral part of overall therapy of severe congestive heart failure. Approximately 10-20 % of patients with congestive heart failure (NYHA class III-IV) do not respond satisfactorily to diuretic treatment. Despite its frequency, the term "diuretic resistance" remains inadequately defined. In general, failure to decrease the extracellular fluid volume despite liberal use of diuretics is often termed "diuretic resistance". The combination of diuretics, particularly of loop diuretic with thiazide agents, is recommended for prevention as well as treatment of this complication. Effective management is also continuous infusion of loop diuretic. If it is impossible to achieve adequate response by combination of diuretics, increasing of its dosage or/and frequency or continuous infusion, then dialysis methods may be employed (however it is not intended to discuss this option in this article).

Keywords: diuretic resistance; heart failure; loop diuretics; combination of diuretics

Received: July 10, 2005; Accepted: March 14, 2006; Published: September 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tůma P, Hrdý P. Diuretics in therapy of "diuretic resistance" by patients with congestive heart failure. Vnitr Lek. 2006;52(9):782-789.
Download citation

References

  1. Špinar J, Hradec J, Málek I et al. Doporučení pro diagnostiku a léčbu chronického srdečního selhání. Cor Vasa 2001; 43: K123-K137.
  2. Aschermann M et al. Kardiologie. Praha: Galén 2004: 2. vol, 908-915.
  3. Publication committee for the VMAC Investigators. Intravenous nesiritide vs. Nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002; 287: 1531-1540.
  4. Rouleau JL, Pfeffer MA, Sestier F et al. Comparison of vasopeptide inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet 2000; 356: 615-620. Go to original source... Go to PubMed...
  5. Follath F, Cleland J, Just H et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low output heart failure (The LIDOStudy): A randomised double-blind trial. Lancet 2002; 360: 196-202. Go to original source... Go to PubMed...
  6. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of Chronic Heart failure (update 2005): The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140. Go to original source... Go to PubMed...
  7. Hunt SA et al. ACC/AHA Guidelines Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committeee to Update the 2001 Gudelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: 1-82. Go to original source... Go to PubMed...
  8. Ellison DH. Diuretic therapy and Resistance in congestive heart failure. Cardiology 2001; 96: 132-143. Go to original source... Go to PubMed...
  9. Knauf H, Mutschler E. Sequential Nephron Blockade Breaks Resistance to Diuretics in Edematous States. J Cardiovasc Pharmacol 1997; 26: 367-372. Go to original source... Go to PubMed...
  10. Ravnan SL, Ravnan MC, Sica DA. Diuretic Resistence and Strategie to Overcome Resistence. Congest Heart Fail 2002; 8: 80-85. Go to original source... Go to PubMed...
  11. Sackler-Berstein JD, Obeleniene R. How Should Diuretic-Refractory, Volume Over-Loaded Heart Failure Patient Be Managed? J Invasive Cardiol 2003; 15: 585-590. Go to PubMed...
  12. Epstein M, Lepp BA, Hoffman DS et al. Potentiation of furosemide by metolazone in refractory edema. Curr Ther Res 1977; 29: 367-372.
  13. Massie BM. Management of the patient with chronic heart failure In: Crawford MH, DiMarco JP (eds). Cardiology. 2. ed. St. Louis: Mosby 2001 5.5.4-5.5.6.
  14. Butler J, Forman DE, Abraham WT et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147: 331-338. Go to original source... Go to PubMed...
  15. Paul S. Balancing Diuretic Therapy in Heart Failure: Loop Diuretics, Thiazides, and Aldosterone Antagonists. Congest Heart Fail 2002; 8: 307-312. Go to original source... Go to PubMed...
  16. Widimský J. Srdeční selhání. Praha: Triton 2001: 110-112.
  17. Šenke M, Eybl V, Hynie S et al. Farmakologie. Praha: Avicenum 1990: 358-369.
  18. De Bruyne LKM. Mechanism and management of diuretic resistance in congestive heart failure. Postgrad Med J 2003; 79: 268-271. Go to original source... Go to PubMed...
  19. Vítovec J, Špinar J, Souček M et al. Farmakoterapie kardiovaskulárních onemocnění. Praha: Grada 2004: 95-104.
  20. Leslie D, Gheorgiade M. Is there a role for thiamine supplementation in the management o heart failure? Am Heart J 1996; 131: 1248-1250. Go to original source... Go to PubMed...
  21. Simon I, Almog S, Vered Z et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995; 98: 485-490. Go to original source... Go to PubMed...
  22. Dahlöf B, Sever PS, Poulter NR et al. Prevention of cardiovascular events with an antihypertensive regiment of amlodipine adding perindopril as required versus atenolol adding bendroflumetiazide as required in the Anglo-Scandinavian Outcomes Trial-Blood Pressure Lowering Arms (ASCOT-BPLA): a multicentre randomised controlled trial. The Lancet 2005; 366: 895-906. Go to original source... Go to PubMed...
  23. Fliser D, Schröter M, Neubeck M et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney International 1994; 46: 482-488. Go to original source... Go to PubMed...
  24. Brater DC. Diuretic Therapy. N Engl J Med 1998; 339: 387-395. Go to original source... Go to PubMed...
  25. Knauf H, Mutschler E. Functional State of Nephron and Diuretic Dose-Response-Rationale for Low-Dose Combination Therapy. Cardiology 1994; 84 (Suppl 2): 18-26. Go to original source... Go to PubMed...
  26. Pitt B, Zannad F, Remme WJ et al. Randomized Aldacton Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717. Go to original source... Go to PubMed...
  27. Pitt B, Remme W, Zannad F et al. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. N Engl J Med 2003; 348: 1309-1321. Go to original source... Go to PubMed...
  28. Van Vliet AA, Donker AJM, Nauta JJP et al. Spironolactone in congestive heart failure refractory to high-dose of loop diuretic and low-dose angiotensin-converging enzyme inhibitor. Am J Cardiol 1993; 71: 21A-28A. Go to original source... Go to PubMed...
  29. Loon NR, Wilcox ChS, Undin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36: 682-689. Go to original source... Go to PubMed...
  30. Ellison DH, Velazquez H, Wright FS et al. Adaptation of the Distal Convoluted Tubule of the Rat, structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 1989; 83: 113-126. Go to original source... Go to PubMed...
  31. Lawson DA, Gray JM, Henry DA et al. Continuous infusion furosemide in refractory edema. Br Med J 1978; 2: 476. Go to original source... Go to PubMed...
  32. Rudy DV, Voelker JR, Greene PK et al. Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion is More Effficacious Than Bolus Therapy. Ann Intern Med 1991; 115: 360-366. Go to original source... Go to PubMed...
  33. Shück O. Poruchy metabolismu vody a elektrolytů v klinické praxi. Praha: Grada 2000: 81-82, 95-105.
  34. Elwell JR, Spenser PA, Eisele G. Combined Furosemide and Human Albumin Treatment for Diuretic-Resistant Edema. Ann Pharmacother 2003; 37: 695-700. Go to original source... Go to PubMed...
  35. Davison AM, Cameron S, Grünfeld JP et al. Oxford Textbook of Clinical Nefrology. Oxford: Oxford University Press 2005: 1485, 2630.
  36. Agostoni P, Marenzi G, Pepi M et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1999; 21: 424-431. Go to original source... Go to PubMed...
  37. Agostoni P, Marenzi G, Lauri G et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency. Am J Med 1994; 96: 191-199. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.